Financhill
Back

Avenue Therapeutics Quote, Financials, Valuation and Earnings

Avenue Therapeutics Price Quote

$4.91
-0.10 (-2%)
(Updated: May 1, 2024 at 6:55 PM ET)

Avenue Therapeutics Key Stats

Sell
19
Avenue Therapeutics (ATXI) is a Sell

Day range:
$4.38 - $5.21
52-week range:
$4.38 - $93.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.87%

Volume:
154.2K
Avg. volume:
40.5K
1-year change:
-92.97%
Market cap:
$3M
Revenue:
$0
EPS:
$-285.75

How Much Does Avenue Therapeutics Make?

Data Unavailable

Is Avenue Therapeutics Growing As A Company?

Data Unavailable

Avenue Therapeutics Stock Price Performance

What Is Avenue Therapeutics 52-Week High & Low?

Avenue Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Avenue Therapeutics?

Is Avenue Therapeutics Cash Flow Positive?

  • What Is ATXI Cash Flow From Operations?
    Cash flow from operations (TTM) is -$9.5M
  • What Is Avenue Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $7.5M
  • What Is Avenue Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Avenue Therapeutics Return On Invested Capital

Data Unavailable

Avenue Therapeutics Earnings Date & Stock Price

Avenue Therapeutics Competitors

Avenue Therapeutics Dividend Yield

Data Unavailable

Avenue Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: -79.24% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 1,228.13
Upside from Last Price: 24413.53%

Major Shareholders

  • How many ATXI shares are owned by institutional investors?
    542.8K ATXI shares are owned by institutional investors
  • How many ATXI shares are owned by insiders?
    1.9M ATXI shares are owned by insiders